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Abstract We report an extremely rare case of a secretory
meningioma primarily involving the temporal bone. A 56-
year old female patient presented to us with a history of a
chronic otitis media and unilateral hearing loss. Diagnostic
investigations revealed a tumor arising from the temporal
bone without signs of intracranial involvement. Histopa-
thological examination showed a meningioma of the secre-
tory type. The tumor was partially resected and serial
imaging at follow-up revealed no extension of the tumor.
No new symptoms developed 1 year after surgery. Secre-
tory meningioma is a rare meningioma subtype and extra-
cranial presentation in the temporal bone is very unusual.
We present the Wrst case of a primary temporal bone secre-
tory meningioma in the otorhinolaryngological literature.
As radical as possible surgical excision with serial imaging
at follow-up is recommended.
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Introduction
Primary extracranial meningiomas of the temporal bone are
rare tumors. In a review of the literature by ‘O Reilly et al.
in 1998 [1], only 26 cases of a primary temporal bone
meningioma were identiWed. Secondary extracranial men-
ingiomas are relatively more common, and they usually
have a large intracranial component that causes neurologi-
cal symptoms. However, primary extracranial meningio-
mas can exist with few or no symptoms and frequently
present with unilateral conductive hearing loss or chronic
otitis media.
Among meningiomas, secretory meningiomas represent
a rare histological subtype. They are characterized by a
unique diVerentiation of meningothelial cells resulting in
the production of hyaline inclusions [2–4, 9]. This article
describes a patient with a primary temporal bone secretory
meningioma presenting as chronic otitis media.
Case report
A 56-year-old woman reported a 5-year history of otitis
media of the right ear and subjective hearing loss. She was
previously treated elsewhere with ventilation tubes and
topical antibiotics. The patient presented to us complaining
of intermittent purulent otorrhoea of the right ear, with otalgia.
She denied any vertigo, imbalance or tinnitus. Her past
medical history was unremarkable.
Physical examination revealed purulent otorrhoea of the
right ear, with the ventilation tube in situ. Rinne testing was
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negative on the right. Neurologic examination, including
evaluation of the cranial nerves, and head and neck exami-
nation were normal.
Audiometry showed a mixed hearing loss of the right ear
with a 40–50 dB conductive component. During the follow-
up there was no signiWcant improvement of signs and
symptoms, and therefore, additional diagnostic imaging
was suggested.
High resolution Computed Tomography (CT) in the
axial plane with coronal reconstructions of the petrous
bones revealed on the right side a soft tissue mass Wlling up
the entire middle ear cavity and mastoid cells (Fig. 1). The
ossicular chain was intact and not displaced. There was no
evidence of destruction of the petrous bone or mastoid.
These Wndings were primary compatible with chronic otitis
media in which a cholesteatoma could not be ruled out.
A middle ear and mastoid exploration was performed via
a combined aproach tympanotomy (CAT). After mastoid-
ectomy, a soft tissue mass was found Wlling the antrum and
middle ear, which bled easily on touch. A clear boundary
between bone and tumor mass was not observed,
suggesting inWltration. The tumor was removed as radical
as possible, with preservation of the ossicular chain and
facial canal. After surgery, the patient recovered promptly
and improvement of hearing was seen.
Histopathological examination of the tumor revealed a
meningioma with numerous intracellular pseudolumina
with round eosinophilic periodic acid SchiV (PAS),
epithelial membrane antigen (EMA) and carcinoembryonic
antigen (CEA) positive bodies, so-called pseudopsammo-
mabodies (Fig. 2). This entity is known as a secretory
meningioma.
Magnetic resonance imaging (MRI) of the head was per-
formed to assess the extent of the tumor. In the middle cra-
nial fossa on the right side, a homogeneous hyper-intense
mass on the axial contrast enhanced T1-WI could be appre-
ciated, in close contact to the temporal bone and with
extension into the sphenoid sinus (Fig. 3a). Thickening and
hyper-intense signal intensity on the T1–WI of the tento-
rium on the right side represent a so-called “dural tail”. On
the coronal and sagittal T1–WI the extension of the mass
into the petrous bone with spread to the epitympanum could
be seen (Fig. 3b, c). The brain parenchyma was unremark-
able.
At 6 months follow-up, MRI showed a slight increase of
tumor volume in the temporal bone without any change of
tumor enhancement of the tentorium. Follow-up at 1 year
showed no changes in tumor volume or extension on MRI.
No new symptoms developed 1 year after surgery. The
patient will be followed for symptoms and signs at regular
intervals with six monthly repeat of MRI.
Discussion
Meningiomas constitute about 18% primary intracranial
tumors [5]. Extracranial extension is seen commonly, but
Fig. 1 High resolution Computed Tomography (CT) in the axial plane
(a) with coronal reconstruction (b) of the petrous bones shows in the
right ear middle ear and mastoid cells a soft tissue mass (asterisks). The
ossicular chain was intact and not displaced. There was no evidence of
destruction of the petrous bone or mastoid
Fig. 2 Secretory meningeoma with many round pseudo-psammoma
bodies (HE, original magniWcation £200)
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primary extracranial meningiomas are rare. They usually
present in the orbit, nasal cavity, paranasal sinuses and
neck [6]. The temporal bone is an unusual site of presenta-
tion. The most common symptoms are sensorineural
hearing loss, headache and vertigo [7]. In our case, the
patient presented with chronic otitis media, which occurs
in 16% all intratympanic meningiomas [7]. This is pre-
sumably the result of obstruction of the Eustachian tube
due to tumor extension into the middle ear cavity. The
diVerential diagnosis of otological symptoms caused by
middle ear tumors includes cholesteatoma, adenoma, para-
ganglioma, adenocarcinoma, lymphoma or metastatic
carcinoma [8].
Temporal bone meningiomas are slow growing
tumors and do not metastasize. After complete resection,
the prognosis is good, with 5-year survival rates of more
than 80% [9]. However, as in our case, complete resec-
tion is often considered not possible and would have
resulted in signiWcant functional impairment of hearing
and balance. As radical as possible surgery based on
optimal improvement of clinical symptoms seems rea-
sonable.
Meningiomas often inWltrate bone along the Haversian
canals, and clear margins are rarely apparent. The recur-
rence rate of ear and temporal bone meningiomas was 28%
in a large patient cohort by Thompson et al. [9]. Therefore
it is essential to follow these patients with serial imaging
studies to detect recurrence and to exclude intracranial
involvement.
There is still debate about the place of radiotherapy in
the treatment of meningiomas. For intracranial meningio-
mas, radiotherapy is frequently recommended as a safe and
reliable adjunctive treatment for partially resected menin-
giomas [10, 11]. The role of radiotherapy for primary extra-
cranial meningiomas has not been established.
According to the WHO classiWcation there are 15 histo-
logic subtypes of meningiomas (Table 1) [12]. Of these
subtypes meningiothelial, Wbrous and transitional (mixed)
are the most common. The prognostic signiWcance of these
subtypes is very low, although some subtypes like clear cell
meningiomas and papillary meningiomas are clinically
aggressive [13].
Meningiomas of the secretory type are rare. Immuno-
histochemical analysis reveals epithelial diVerentiation
Fig. 3 a Post-contrast T1–WI MRI of the head. In the middle cranial
fossa on the right side, a homogeneous hyper-intense mass on the axial
plane can be seen (asterisk), in close contact to the temporal bone. Also
thickening and hyper-intense signal intensity of the tentorium (arrows)
represent the “dural tail”. b, c On the coronal and sagittal images the
extension of the mass into the petrous bone with spread to the epitymp-
anon can be seen (small arrows)
Table 1 [12] World Health Organisation (WHO) classiWcation of
meningiomas
WHO grade
Meningiomas with low risk of recurrence or 
aggressive growth
Meningothelial I
Fibrous (Wbroblastic) I
Transitional (mixed) I
Psammomatous I
Angiomatous I
Microcystic I
Secretory I
Lymphoplasmacyte-rich I
Metaplastic I
Meningiomas with greater likelihood of 
recurrence and/or aggressive behavior
Atypical II
Clear cell (intracranial) II
Chordoid II
Rhabdoid III
Papillary III
Anaplastic (malignant) III
Meningiomas of any subtype or grade with 
high proliferative index and/or brain invasion
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features reXecting the pluropotential of cap cells. Intra-
cellular lumina containing secretory lobules and eosino-
philic (hyaline) inclusions are their distinguishing
histological features [2–4]. In 1986 Alguacil-Garcia
et al. [2] has determined the secretory features of these
meningiomas thus suggested the name secretory
meningioma. Formerly, these inclusions were referred to
as “pseudopsammoma bodies” after a publication by
Kepes et al. [3].
The frequency of secretory meningiomas is reported
in the literature as approximately 1.6–3% [2, 4, 9]. Only
119 cases have been reported until present [14]. All were
located intracranially. Only one case of a secretory
meningioma primarily involving the temporal bone has
been recently reported by Ereno et al. [15]. They pre-
sented a patient with a history of increasing left hypoa-
cusis and sporadic vertigo. CT scan revealed a tumor
occupying the mastoid, middle ear and external auditory
canal. The tumor preserved the bone integrity without
disruption of the temporal inner table, and was surgi-
cally removed. A typical secretory meningioma was
diagnosed. The main emphasis in their article was on
histopathology. Treatment and follow-up were not
discussed.
Clinically, intracranial secretory meningiomas are asso-
ciated with a good prognosis. In a large case study by
Probst et al. [4], 31 patients with an intracranial secretory
meningioma were followed after surgical removal of the
tumor, with an average observation time of 23 months. No
recurrences occurred during the follow-up, which ranged
from 1 month to 8 years.
To conclude, meningiomas arising from the temporal
bone are rare. And the secretory type is extremely rare. As
radical as possible surgical excision with serial imaging at
follow-up is recommended.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution Noncommercial License which permits any
noncommercial use, distribution, and reproduction in any medium,
provided the original author(s) and source are credited.
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